Reem H Ghalib MD

Hepatology & Liver Transplantation

Physician

1001 N Waldrop DrSte 509Arlington, TX 76012
Phone+1 817-394-4300
Fax+1 817-394-0200

Dr. Ghalib is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Ghalib's full profile Already have an account?

Education & Training

Washington University/B-JH/SLCH ConsortiumFellowship, Gastroenterology, 1993 - 1996
Baylor College of MedicineResidency, Internal Medicine, 1990 - 1993
Kuwait University Faculty of MedicineClass of 1989

The following disclaimer is related to board certifications obtained from ABMS®, denoted by the ABMS® logo.

This information is proprietary data maintained in a copyrighted database owned by the American Board of Medical Specialties®. The display and presence of ABMS Data in no way constitutes any affiliation, association with, or endorsement of any advertising, promotion, or sponsorship by ABMS and its affiliates and subsidiaries, the ABMS Member Boards, or ABMS board certified physicians and medical specialists. Copyright 2026 American Board of Medical Specialties®. All rights reserved.

The user is responsible for ensuring that the profile obtained in this directory is the profile of the physician or medical specialist being sought.

A self-designated specialty, subspecialty, or practice area neither implies nor is equivalent to ABMS board certification or the existence of specialized training by or competence of a physician or medical specialist.

Certifications & Licensure

FL State Medical License 2025 - 2027
TX State Medical License 1999 - 2026
American Board of Internal Medicine Gastroenterology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification gGastro, gMed, Inc., 2013-2014
CMS Meaningful Use Stage 2 Certification gGastro, gMed, Inc., 2013-2014

Clinical Trials

Clinical Trial to Evaluation the Safety and Efficacy of GR-MD-02 for the Treatment of Liver Fibrosis and Resultant Portal Hypertension in Patients With Nash Cirrhosis
COMPLETED
PHASE2
A Study to Assess the Safety, Tolerability, Pharmacokinetics and Efficacy of EDP-305 in Subjects With Non-Alcoholic Steatohepatitis Start of enrollment: 2018 Apr 25
COMPLETED
PHASE2

Publications & Presentations

PubMed

12 citations
High Sustained Virologic Response Rates of Glecaprevir/Pibrentasvir in Patients With Dosing Interruption or Suboptimal Adherence.
Philippe J. Zamor, Ashley Brown, Douglas E. Dylla, John F. Dillon, Anne F Luetkemeyer
The American Journal of Gastroenterology. 2021-09-01
217 citations
Combination Therapies Including Cilofexor and Firsocostat for Bridging Fibrosis and Cirrhosis Attributable to NASH
Rohit Loomba, Mazen Noureddin, Kris V. Kowdley, Anita Kohli, Aasim Sheikh
Hepatology. 2021-02-01
46 citations
Emricasan to prevent new decompensation in patients with NASH-related decompensated cirrhosis
Catherine Frenette, Zeid Kayali, Edward Mena, Parvez S. Mantry, Kathryn J. Lucas
Journal of Hepatology. 2021-02-01